Search

Your search keyword '"Buonaguro, Luigi"' showing total 783 results
Start Over Author "Buonaguro, Luigi"
783 results on '"Buonaguro, Luigi"'

5. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients

Author

Tornesello, Anna Lucia, Botti, Chiara, Micillo, Alberto, Labonia, Francesco, Arpino, Sergio, Isgrò, Maria Antonietta, Meola, Serena, Russo, Luigi, Cavalcanti, Ernesta, Sale, Silvia, Nicastro, Carmine, Atripaldi, Luigi, Starita, Noemy, Cerasuolo, Andrea, Reimer, Ulf, Holenya, Pavlo, Buonaguro, Luigi, Buonaguro, Franco M., and Tornesello, Maria Lina

Published
2023
Full Text
View/download PDF

7. Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

Author

Ascierto, Paolo A, Bifulco, Carlo, Buonaguro, Luigi, Emens, Leisha A, Ferris, Robert L, Fox, Bernard A, Delgoffe, Greg M, Galon, Jérôme, Gridelli, Cesare, Merlano, Marco, Nathan, Paul, Odunsi, Kunle, Okada, Hideho, Paulos, Chrystal M, Pignata, Sandro, Schalper, Kurt A, Spranger, Stefani, Tortora, Giampaolo, Zarour, Hassane, Butterfield, Lisa H, and Puzanov, Igor

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Vaccine Related, Rare Diseases, Immunization, Orphan Drug, Cancer, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Good Health and Well Being, Antineoplastic Agents, Immunological, Biomarkers, Tumor, Humans, Immunotherapy, Molecular Targeted Therapy, Neoplasms, T-Lymphocytes, Checkpoint inhibitors, Combination therapy, Biomarkers, Tumor microenvironment, Oncology and carcinogenesis
Abstract

Immunotherapy is now widely established as a potent and effective treatment option across several types of cancer. However, there is increasing recognition that not all patients respond to immunotherapy, focusing attention on the immune contexture of the tumor microenvironment (TME), drivers of the immune response and mechanisms of tumor resistance to immunity. The development of novel immunotherapeutics and their use in combination with checkpoint inhibitors and other standard of care and novel treatment modalities is an area of particular attention across several tumor types, including melanoma, lung, ovarian, breast, pancreatic, renal, head and neck, brain and non-melanoma skin cancers. The 4th Immunotherapy Bridge meeting (28-29 November, 2018, Naples, Italy) focused on a wide range of evolving topics and trends in the field of cancer immunotherapy and key presentations from this meeting are summarised in this report.

Published
2019

10. Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021

Author

Ascierto, Paolo A., Avallone, Antonio, Bhardwaj, Nina, Bifulco, Carlo, Bracarda, Sergio, Brody, Joshua D., Buonaguro, Luigi, Demaria, Sandra, Emens, Leisha A., Ferris, Robert L., Galon, Jérôme, Khleif, Samir N., Klebanoff, Christopher A., Laskowski, Tamara, Melero, Ignacio, Paulos, Chrystal M., Pignata, Sandro, Ruella, Marco, Svane, Inge Marie, Taube, Janis M., Fox, Bernard A., Hwu, Patrick, and Puzanov, Igor

Published
2022
Full Text
View/download PDF

14. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buvé, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Hervé, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Kirtley, Shona, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2020
Full Text
View/download PDF

15. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization.

Author

Ragone, Concetta, Mauriello, Angela, Cavalluzzo, Beatrice, Cavalcanti, Ernesta, Russo, Luigi, Manolio, Carmen, Mangano, Simona, Cembrola, Biancamaria, Tagliamonte, Maria, and Buonaguro, Luigi

Subjects
MOLECULAR mimicry, VIRAL proteins, T cells, COVID-19 vaccines, COVID-19 pandemic
Abstract

Background: In the present study we investigated whether peptides derived from the entire SARS-CoV-2 proteome share homology to TAAs (tumor-associated antigens) and cross-reactive CD8+ T cell can be elicited by the BNT162b2 preventive vaccine or the SARS-CoV-2 natural infection. Methods and results: Viral epitopes with high affinity (<100nM) to the HLAA* 02:01 allele were predicted. Shared and variant-specific epitopes were identified. Significant homologies in amino acidic sequence have been found between SARS-CoV-2 peptides and multiple TAAs, mainly associated with breast, liver, melanoma and colon cancers. The molecular mimicry of the viral epitopes and the TAAs was found in all viral proteins, mostly the Orf 1ab and the Spike, which is included in the BNT162b2 vaccine. Predicted structural similarities confirmed the sequence homology and comparable patterns of contact with both HLA and TCR α and β chains were observed. CD8+ T cell clones cross-reactive with the paired peptides have been found by MHC class l-dextramer staining. Conclusions: Our results show for the first time that several SARS-COV-2 antigens are highly homologous to TAAs and cross-reactive T cells are identified in infected and BNT162b2 preventive vaccinated individuals. The implication would be that the SARS-Cov-2 pandemic could represent a natural preventive immunization for breast, liver, melanoma and colon cancers. In the coming years, real-world evidences will provide the final proof for such immunological experimental evidence. Moreover, such SARS-CoV-2 epitopes can be used to develop "multicancer" off-the-shelf preventive/therapeutic vaccine formulations, with higher antigenicity and immunogenicity than over-expressed tumor self-antigens, for the potential valuable benefit of thousands of cancer patients around the World. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Assessment of Primary Human Liver Cancer Cells by Artificial Intelligence-Assisted Raman Spectroscopy

Author

Esposito, Concetta, primary, Janneh, Mohammed, additional, Spaziani, Sara, additional, Calcagno, Vincenzo, additional, Bernardi, Mario Luca, additional, Iammarino, Martina, additional, Verdone, Chiara, additional, Tagliamonte, Maria, additional, Buonaguro, Luigi, additional, Pisco, Marco, additional, Aversano, Lerina, additional, and Cusano, Andrea, additional

Published
2023
Full Text
View/download PDF

19. 1541 Stability of the gut microbiota during anti-pd1 immunotherapy defines complete response in melanoma patients

Author

Macandog, Angeli DG, primary, Catozzi, Carlotta, additional, Capone, Mariaelena, additional, Nabinejad, Amir, additional, Madonna, Gabriele, additional, Barberis, Massimo, additional, Ferrucci, Pier, additional, Segata, Nicola, additional, Buonaguro, Luigi, additional, Cocorocchio, Emilia, additional, Ascierto, Paolo A, additional, Manzo, Teresa, additional, and Nezi, Luigi, additional

Published
2023
Full Text
View/download PDF

24. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buve, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Herve, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano Kaleebu, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Fleminger, Isabella, Kirtley, Shona, Williams, Brian, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2019
Full Text
View/download PDF

25. Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs).

Author

Cavalluzzo, Beatrice, Viuff, Marie Christine, Tvingsholm, Siri Amanda, Ragone, Concetta, Manolio, Carmen, Mauriello, Angela, Buonaguro, Franco M., Tornesello, Maria Lina, Izzo, Francesco, Morabito, Alessandro, Hadrup, Sine Reker, Tagliamonte, Maria, and Buonaguro, Luigi

Subjects
T cells, BACTERIAL antigens, ANTIGENS, CELLULAR recognition, CELL populations, POSTTRAUMATIC growth
Abstract

Background: We have recently shown extensive sequence and conformational homology between tumor-associated antigens (TAAs) and antigens derived from microorganisms (MoAs). The present study aimed to assess the breadth of T-cell recognition specific to MoAs and the corresponding TAAs in healthy subjects (HS) and patients with cancer (CP). Method: A library of > 100 peptide-MHC (pMHC) combinations was used to generate DNA-barcode labelled multimers. Homologous peptides were selected from the Cancer Antigenic Peptide Database, as well as Bacteroidetes/Firmicutes-derived peptides. They were incubated with CD8 + T cells from the peripheral blood of HLA-A*02:01 healthy individuals (n = 10) and cancer patients (n = 16). T cell recognition was identified using tetramer-staining analysis. Cytotoxicity assay was performed using as target cells TAP-deficient T2 cells loaded with MoA or the paired TuA. Results: A total of 66 unique pMHC recognized by CD8+ T cells across all groups were identified. Of these, 21 epitopes from microbiota were identified as novel immunological targets. Reactivity against selected TAAs was observed for both HS and CP. pMHC tetramer staining confirmed CD8+ T cell populations cross-reacting with CTA SSX2 and paired microbiota epitopes. Moreover, PBMCs activated with the MoA where shown to release IFNγ as well as to exert cytotoxic activity against cells presenting the paired TuA. Conclusions: Several predicted microbiota-derived MoAs are recognized by T cells in HS and CP. Reactivity against TAAs was observed also in HS, primed by the homologous bacterial antigens. CD8+ T cells cross-reacting with MAGE-A1 and paired microbiota epitopes were identified in three subjects. Therefore, the microbiota can elicit an extensive repertoire of natural memory T cells to TAAs, possibly able to control tumor growth ("natural anti-cancer vaccination"). In addition, non-self MoAs can be included in preventive/therapeutic off-the-shelf cancer vaccines with more potent anti-tumor efficacy than those based on TAAs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells

Author

Caputo, Tania Mariastella, primary, Cusano, Angela Maria, additional, Principe, Sofia, additional, Cicatiello, Paola, additional, Celetti, Giorgia, additional, Aliberti, Anna, additional, Micco, Alberto, additional, Ruvo, Menotti, additional, Tagliamonte, Maria, additional, Ragone, Concetta, additional, Minopoli, Michele, additional, Carriero, Maria Vincenza, additional, Buonaguro, Luigi, additional, and Cusano, Andrea, additional

Published
2023
Full Text
View/download PDF

33. Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8+ T cell immunity in CLL and MDS patients

Author

Hernandez, Susana Patricia Amaya, primary, Hersby, Ditte Stampe, additional, Munk, Kamilla Kjærgaard, additional, Tamhane, Tripti, additional, Trubach, Darya, additional, Tagliamonte, Maria, additional, Buonaguro, Luigi, additional, Gang, Anne Ortved, additional, Hadrup, Sine Reker, additional, and Saini, Sunil Kumar, additional

Published
2023
Full Text
View/download PDF

34. Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

Author

Löffler, Markus W., Mohr, Christopher, Bichmann, Leon, Freudenmann, Lena Katharina, Walzer, Mathias, Schroeder, Christopher M., Trautwein, Nico, Hilke, Franz J., Zinser, Raphael S., Mühlenbruch, Lena, Kowalewski, Daniel J., Schuster, Heiko, Sturm, Marc, Matthes, Jakob, Riess, Olaf, Czemmel, Stefan, Nahnsen, Sven, Königsrainer, Ingmar, Thiel, Karolin, Nadalin, Silvio, Beckert, Stefan, Bösmüller, Hans, Fend, Falko, Velic, Ana, Maček, Boris, Haen, Sebastian P., Buonaguro, Luigi, Kohlbacher, Oliver, Stevanović, Stefan, Königsrainer, Alfred, HEPAVAC Consortium, and Rammensee, Hans-Georg

Published
2019
Full Text
View/download PDF

44. Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

Author

Ascierto, Paolo A., Brugarolas, James, Buonaguro, Luigi, Butterfield, Lisa H., Carbone, David, Daniele, Bruno, Ferris, Robert, Fox, Bernard A., Galon, Jérôme, Gridelli, Cesare, Kaufman, Howard L., Klebanoff, Christopher A., Melero, Ignacio, Nathan, Paul, Paulos, Chrystal M., Ruella, Marco, Sullivan, Ryan, Zarour, Hassane, and Puzanov, Igor

Published
2018
Full Text
View/download PDF

48. Three-doses of BNT162b2 COVID-19 mRNA vaccine establishes long-lasting CD8+ T cell immunity in CLL and MDS patients

Author

Amaya Hernandez, Susana Patricia, primary, Hersby, Ditte Stampe, additional, Munk, Kamilla Kjærgaard, additional, Tamhane, Tripti, additional, Trubach, Darya, additional, Tagliamonte, Maria, additional, Buonaguro, Luigi, additional, Gang, Anne Ortved, additional, Hadrup, Sine Reker, additional, and Saini, Sunil Kumar, additional

Published
2022
Full Text
View/download PDF

49. Profiling the HCV Immune Response in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma by Peptide Microarray Analysis

Author

Tornesello, Anna Lucia, primary, Reimer, Ulf, additional, Holenya, Pavlo, additional, Knaute, Tobias, additional, Pezzuto, Francesca, additional, Izzo, Francesco, additional, Buonaguro, Luigi, additional, Megna, Angelo Salomone, additional, Buonaguro, Franco Maria, additional, and Tornesello, Maria Lina, additional

Published
2022
Full Text
View/download PDF

50. Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma

Author

Löffler, Markus W., primary, Gori, Stefania, additional, Izzo, Francesco, additional, Mayer-Mokler, Andrea, additional, Ascierto, Paolo A., additional, Königsrainer, Alfred, additional, Ma, Yuk Ting, additional, Sangro, Bruno, additional, Francque, Sven, additional, Vonghia, Luisa, additional, Inno, Alessandro, additional, Avallone, Antonio, additional, Ludwig, Jörg, additional, Alcoba, Diego Duarte, additional, Flohr, Christian, additional, Aslan, Katrin, additional, Mendrzyk, Regina, additional, Schuster, Heiko, additional, Borrelli, Marco, additional, Valmori, Danila, additional, Chaumette, Tanguy, additional, Heidenreich, Regina, additional, Gouttefangeas, Cécile, additional, Forlani, Greta, additional, Tagliamonte, Maria, additional, Fusco, Caterina, additional, Penta, Roberta, additional, Iñarrairaegui, Mercedes, additional, Gnad-Vogt, Ulrike, additional, Reinhardt, Carsten, additional, Weinschenk, Toni, additional, Accolla, Roberto S., additional, Singh-Jasuja, Harpreet, additional, Rammensee, Hans-Georg, additional, and Buonaguro, Luigi, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results